This page contains brief information about tafasitamab-cxix and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Tafasitamab-cxix is approved to treat:
- Diffuse large B-cell lymphoma (certain types) that has relapsed (come back) or is refractory (does not respond to treatment). It is used with lenalidomide in adults who cannot receive an autologous stem cell transplant.
This use is approved under FDA’s Accelerated Approval Program. As a condition of approval, a confirmatory trial(s) must show that tafasitamab-cxix provides a clinical benefit in these patients.
Tafasitamab-cxix is also being studied in the treatment of other types of cancer.
More About Tafasitamab-cxix
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Tafasitamab-cxix - Check for trials from NCI's list of cancer clinical trials now accepting patients.